Towards a better characterized, broadly applicable, and safer DNA-based antibody platform

This abstract was selected by our Scientific Committee to pitch on the programme in the R2B session (PM).

This abstract is not published by request of the author.

Authors

Organisations

Presenting author

Giles Vermeire, PhD Student, Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven - University of Leuven
giles.vermeire@kuleuven.be
Contact us now
REGISTER AS A DELEGATE NOW

Flanders.bio Strategic Partners

Flanders.bio Supporting Partners